APTITUDE MEDICAL SYSTEMS INC - ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND BEYOND
Key Details
Description
ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND BEYOND
Context & Analysis
On Nov 13, 2025, Department of Health and Human Services obligated $33,771,970 to APTITUDE MEDICAL SYSTEMS INC for ace rapid molecular test system for point of care (poc) and in-home use with saliva and swab samples for covid-19 and beyond. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in OWINGS MILLS, MD. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.